Several classes of new drugs emerging for Parkinson disease.
Phillips
P
P
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D052160:Benzothiazoles; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D009570:Nitriles; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D013844:Thiazoles / Q000627:therapeutic use
D000978:Antiparkinson Agents; D052160:Benzothiazoles; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D018491:Dopamine Agonists; D004791:Enzyme Inhibitors; D007211:Indoles; D009570:Nitriles; D013844:Thiazoles; C046649:ropinirole; D007980:Levodopa; C071192:entacapone; D000077487:Pramipexole